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A B S T R A C T   
Progesterone is the predominant gestagen in most mammals studied so far. It plays a substantial role in the 
regulation of the female reproductive cycle and in providing support for pregnancy maintenance. Despite its 
known functions, gaps in knowledge are present regarding its reduced metabolites that potentially exert bio-
logical activity. Therefore, a new UHPLC-HRMS method based on a Q Exactive™ mass spectrometer was 
developed to detect and quantify simultaneously progesterone, its hormone precursor pregnenolone and 10 
reduced progestogens (20α-DHP, 20β-DHP, 3α,5α-THP, 3α,5β-THP, 3β,5α-THP, 3β,5β-THP, 3α-DHP, 3β-DHP, 5α- 
DHP and 5β-DHP) in plasma and serum samples. Purification was achieved by an optimized solid phase 
extraction (SPE) and the analysis was conducted in positive electrospray ionization (ESI) mode with the appli-
cation of multiplexed selected ion monitoring (msx-t-SIM). The method validation included the study of sensi-
tivity, selectivity, curve fitting, carry-over, accuracy, precision, recovery and matrix effects. Despite the poor 
ionization properties of underivatized steroids, a high sensitivity in the range of pg/mL was achieved.   
1. Introduction 
Progesterone (P4) is a steroid hormone mainly synthesized by the 
corpus luteum in the female ovary, the placenta and the adrenal cortex 
[1]. Its physiology, production and mode of action have been studied 
thoroughly. P4 plays a key role in the maintenance of pregnancy [2] as 
well as during the development of mammary glands [3]. Additionally, 
its route of inactivation has been determined in detail [4]. 
The discovery of neuroactive steroids interacting with receptors and 
ion channels in the brain eventually widened the interest in unravelling 
the role of progesterone metabolites. A series of 3 alpha-hydroxy ring A- 
reduced pregnane steroids that own sedative, anxiolytic and anticon-
vulsant attributes such as allopregnanolone (5α-pregnan-3α-ol-20-one) 
or pregnanolone (5β-pregnan-3α-ol-20-one) belong to the category of 
neuroactive steroids. They bind with a high affinity and stereo-
selectively to γ-aminobutyric acid receptors (GABAA) and are thus an 
important part of the central nervous system [5–7]. Furthermore, 
several reports were released on the correlation of 5α-dihy-
droprogesterone (5α-DHP) and 3α-dihydroprogesterone (3α-DHP) levels 
in the context of breast cancer [4,8,9]. Thereby, tumorous breast tissue 
was found to produce higher levels of 5α-DHP and decreased levels of 
3α-DHP compared to healthy tissue. Whereas 5α-DHP promoted cell 
proliferation and detachment in cancerous tissue, 3α-DHP showed to 
have an opposite effect. In addition, first evidence was provided that 
3α-DHP suppresses mitosis while stimulating apoptosis. Again, 5α-DHP 
acting as a counterpart exhibited the reverse impact. Blackmore [9] 
showed that various progesterone metabolites including epipreg-
nanolone (5β-pregnan-3β-ol-20-one) and 20α-dihydroprogesterone 
(20α-DHP) were able to act as potent stimulators of free Ca2+ influx and 
intracellular Ca2+ mobilization in human platelets. Additionally, some 
5α/β-reduced progesterone metabolites were reported to display further 
functions during pregnancy such as influencing the pain perception of 
mother and fetus as well as protecting nerve cells against hypoxic stress 
[11,12]. 
The progesterone metabolism illustrated in Fig. 1 shows the 
complexity of its reductions which primarily take place in the liver and 
the ovarian tissue [11,13–15]. Due to the two ketone groups and a 
Δ4-double bond, P4 is highly vulnerable to enzymatic reductions by 
reductases (5α- and 5β-reductase) and hydroxysteroid dehydrogenases 
(3α-, 3β-, 20α-, and 20β-hydroxysteroid dehydrogenase), reactions that 
are classified as phase I metabolisms. In non-conjugated reduced prod-
ucts, a theoretical vast number of 26 metabolites can be formed through 
* Corresponding author. 
E-mail address: laurent.bigler@chem.uzh.ch (L. Bigler).  
Contents lists available at ScienceDirect 
Talanta 
journal homepage: www.elsevier.com/locate/talanta 
https://doi.org/10.1016/j.talanta.2021.122358 
Received 23 December 2020; Received in revised form 19 March 2021; Accepted 20 March 2021   
Talanta 232 (2021) 122358
2
combination of all six enzymes. Of these, 18 have been already detected 
in blood, urine and/or faeces [14]. 
Since the 1970s, a substantial number of immunoassays was devel-
oped for the sensitive and specific detection of sexual steroids, one of the 
first being a radioimmunoassay (RIA) for 17β-estradiol by G. E. Abraham 
[15]. Immunoassays are inexpensive, fast, require small sample volumes 
and can be up-scaled for a high sample throughput but are also known to 
lack unique specificity due to potential cross-reactivity of the antibody 
with other similar-structured compounds [16–20]. In contrast, gas 
chromatography-mass spectrometry (GC/MS) as well as liquid 
chromatography-mass spectrometry (LC/MS) provide good linearity 
even down to low concentrations while also providing superior selec-
tivity by chromatographic and mass-based separation of related steroid 
structures [18]. As steroids most often possess polar hydroxyl and ke-
tone groups, a GC/MS analysis requires that these functional groups 
have to be replaced by derivatization to obtain sufficient volatility and 
thermal stability [19]. This labor-intensive preparation step can be 
omitted when working with LC/MS, allowing sensitive detection of the 
analytes by electrospray ionization (ESI) or atmospheric pressure 
chemical ionization (APCI). Using these methods, various steroid ad-
ducts such as [M+H]+, [M + NH4]+, [M + HCOO]– or [M+F]– can be 
effectively generated [20]. 
Fig. 1. First steps of the reductive biosynthetic pathway of progesterone into its metabolites (based on source [10,12,14] and [13]).  
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This study describes the establishment and validation of an UHPLC- 
HRMS method for the simultaneous detection and quantification of 
progesterone, its biological precursor pregnenolone and 10 reduced 
progesterone metabolites (20α-DHP, 20β-DHP, 3α,5α-THP, 3α,5β-THP, 
3β,5α-THP, 3β,5β-THP, 3α-DHP, 3β-DHP, 5α-DHP and 5β-DHP) in 
plasma and serum samples (500 μL). Despite the poor ionization effi-
ciency of steroids [21,22], we achieved a high sensitivity in the range of 
pg/mL without the need of derivatization. Selectivity was ensured by 
applying the high-resolution t-SIM (targeted single ion monitoring) 
mode. Research based on the quantification of large sample numbers is 
easily conductible due to the high throughput that we achieved by an 
efficient solid phase extraction protocol and a short chromatographic 
separation time. 
2. Materials and method 
2.1. Chemicals and reagents 
Commercial steroid reference materials of 4-pregnen-3,20-dione 
(P4), 5-pregnen-3β-ol-20-one (P5), 5-pregnen-3β-ol-20-one- 
17,21,21,21-d4 (P5-d4), 5β-pregnan-3,20-dione (5β-DHP), 5α-pregnan- 
3,20-dione (5α-DHP), 5α-pregnan-3α-ol-20-one (3α,5α-THP), 5α-preg-
nan-3β-ol-20-one (3β,5α-THP), 5β-pregnan-3α-ol-20-one (3α,5β-THP), 
5β-pregnan-3β-ol-20-one (3β,5β-THP), 4-pregnen-3α-ol-20-one (3α- 
DHP), 4-pregnen-3β-ol-20-one (3β-DHP), 4-pregnen-20α-ol-3-one (20α- 
DHP), 4-pregnen-20β-ol-3-one (20β-DHP) and 4-pregnen-3,20-dione- 
2,2,4,6,6,17α,21,21,21-d9 (P4-d9) were obtained from Steraloids 
(Newport, RI, USA). ULC-MS grade acetonitrile together with MeOH 
were from Biosolve BV (Valkenswaard, Netherlands). Formic acid (LC- 
MS grade) and ortho-phosphoric acid (85%, puriss p.a. grade) were 
supplied by Fluka (Buchs, SG, Switzerland). Ultrapure water (<2 ppb 
TOC) was produced using a Milli-Q® Advantage A10 water purification 
system by Merck (Bedford, MA, USA). Charcoal stripped bovine plasma 
of a domestic cattle collected 9 days postpartum was used as a surrogate 
matrix. 
2.2. Standard solutions 
Analytical standard solutions were stored at −20 ◦C until use. Stock 
solutions were prepared individually at 50 μg/mL by dissolving an ac-
curate weight of the reference material in MeOH. Mixed working solu-
tions were prepared in MeOH as a dilution series at the concentrations of 
1000, 500, 50, 5.0 and 0.5 ng/mL of each steroid for the method opti-
mization and the preparation of calibration and quality control samples. 
The internal standards (ISTD) P5-d4 and P4-d9 were mixed in an 
aqueous working solution at concentrations of 1 and 5 ng/mL, 
respectively. 
2.3. Sample preparation 
Plasma and serum samples were thawed at room temperature 
(22 ◦C). To prepare the samples for the calibration curve, an aliquot of 
the working standard solutions was spiked into charcoal stripped plasma 
to obtain the desired end concentration prior to the purification step. 
Quality control (QC) samples were prepared in the same fashion at 
three-levelled concentrations of choice (low, middle, high). For the 
evaluation of recovery and matrix effects, post-extracted blank plasma 
as well as neat solvent were spiked at three different concentrations 
covering the whole calibration range. 
Following SPE protocol was developed on the basis of Strata-X (3 mL, 
60 mg) polymeric reversed phase cartridges from Phenomenex (Tor-
rance, CA, USA): Conditioning of the cartridges with 2 mL MeOH fol-
lowed by equilibration with 2 mL H2O; mixing 500 μL plasma with 500 
μL of 4% aqueous H3PO4 and 1 mL aqueous ISTD (P5-d4 and P4-d9 at 
final concentrations of 5 and 1 ng/mL, respectively) solutions in a 5 mL 
Eppendorf tube; vortexed for 10 s. The sample mixture was loaded onto 
the sorbent and subsequently washed with 2 mL H2O and an aqueous 
solution of 2 mL 40% MeCN/MeOH (85:15). Next, the sorbent was dried 
under vacuum (250–380 mm Hg) for 1 min. The steroids were then 
eluted using 2 mL 90% MeCN/MeOH (85:15), evaporated to dryness at 
40 ◦C under a continuous flow of N2 and reconstituted in 50 μL MeCN/ 
H2O 1:1 containing 0.1% formic acid. 5 μL of the final solution was 
injected for analysis. This protocol was also applied to all standard, QC 
and blank samples. 
2.4. Chromatography 
Liquid chromatography was performed on a Thermo Fisher UltiMate 
3000 UHPLC (Waltham, MA, USA) build from a binary RS pump, an XRS 
open autosampler, a temperature-controllable RS column compartment. 
Sample separation was achieved at 25 ◦C on an ACQUITY UPLC HSS T3 
column (2.1 × 100 mm, 1.8 μm particle size) protected by the corre-
sponding HSS T3 VanGuard pre-column (2.1 × 5 mm, 1.8 μm particle 
size) and a Critical Clean ACQUITY guard filter (0.2 μm, 2.1 mm) from 
Waters (Milford, MA, USA). Eluent A consisted of H2O and eluent B of 
acetonitrile, both acidified with 0.1% formic acid. The following 
gradient was applied at a constant flow rate of 450 μL/min: (i) 58% B 
isocratic from 0.0 to 0.5 min; (ii) linear increase to 62% B until 3.7 min; 
(iii) ramping to 66% until 6.0 min; (iv) switch to 100% B from 6 to 6.1 
min; (v) holding 100% B until 10.0 min (vi) change until 10.1 min to the 
starting conditions of 58% B; (vii) equilibration for 3.9 min resulting in a 
total run time of 14 min. 
2.5. Mass spectrometry 
Mass spectra were acquired on a Thermo Fisher Scientific Q Exactive 
hybrid quadrupole-Orbitrap mass spectrometer (Waltham, MA, USA) 
equipped with a heated ESI source at position B and a voltage of 3.5 kV. 
Sheath, auxiliary and sweep gas (N2) flow rates were fixed at 45, 15 and 
2 (arbitrary units), respectively. The capillary temperature amounted 
250 ◦C and the auxiliary gas heater temperature was 450 ◦C. The S-lens 
RF level was set at 55.0. Multiplexed t-SIM in positive operation was 
chosen as the acquisition mode monitoring the most abundant ions of 
the investigated progestagens as listed in Table 1. The instrument was 
calibrated at a mass accuracy ≤ 2 ppm with a PierceTM LTQ Velos ESI 
Positive Ion Calibration Solution (Thermo). Further parameters were 
35,000 full width at half maximum (FWMH) resolution at 200 m/z, a 
maximum IT of 57 ms, and an AGC target of 1e5. MS parameters were 
optimized by continuous flow injection (1 μL/min, Chemyx Fusion 101 
HESI syringe pump, Chemyx, Stafford, TX, USA) of a solution containing 
a mixture of the progestogen standards (1000 ng/mL). Xcalibur 4.1 and 
TraceFinder 4.1 software (Thermo Fisher Scientific) were employed for 
data acquisition, peak-area integration and quantitation. A 15 ppm mass 
tolerance was set for peak detection. 
2.6. Method validation 
2.6.1. Selectivity 
Chromatographic conditions were optimized and the targeted ions 
were selected with the mixed working solutions (see Chap. 2.2). Blank 
plasma and a calibration sample were injected and compared for the 
further investigation of interferences and selectivity. The minimum 
quality criteria required for the blank matrix used for QC and calibration 
sample preparation were signal responses below 20% of the limit of 
quantification (LOQ) for each analyte. Concerning the ISTD, a signal 
response under the LOD needed to be secured. 
2.6.2. Carry-over 
Blank samples (neat MeOH and blank plasma) were analyzed after 
the injection of a highly concentrated working standard solution (1000 
ng/mL) in order to investigate possible carry-over. Again, carry-over in 
the blank samples should be lower than 20% of the signal response at the 
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LOQ and neglectable for the ISTD. 
2.6.3. Curve plotting and sensitivity 
For the quantification method, internal standards were added to the 
samples. The ratios of the peak areas of the analytes and their corre-
sponding ISTDs were then plotted as a function of analyte concentration 
using least-squares linear regressions. A first set of calibrators (0.005, 
0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 15, 20, 30, 80, 240 ng/mL) was 
measured to determine the dynamic range, the limit of detection (LOD) 
and the limit of quantification (LOQ). The decision between linear and 
quadratic fitting was based on the obtained correlation coefficient R or 
R2 that defines the accuracy of the plotting. A fit was considered as 
acceptable if R or R2 were >0.99. Weighting functions were alike 
selected depending on the lowest bias. The LOD was reached at the 
analyte concentration which delivered a signal to background noise 
ratio higher than 3. For the specification of the LOQ, an S/N ratio of 
approximately 10 is required. For the quantification of authentic sam-
ples, the dynamic range was limited (0.02, 0.05, 0.1, 0.2, 0.5, 1, 5, 10 
and 20 ng/mL) matching the relevant range of biological systems. P5-d4 
or P4-d9 were chosen individually as an ISTD for each analyte 
depending on similarities in ionization behavior (see Table 1). 
2.6.4. Accuracy and precision 
Accuracy and precision were investigated using QC samples at three 
different concentrations. For the low QC sample, 0.06 ng/mL of P4, P5, 
3β-DHP, 20α-DHP and 20β-DHP, 0.2 ng/mL of 5α-DHP, 5β-DHP, 3α- 
DHP, 3α,5α-THP, 3α,5β-THP, 3β,5α-THP and 0.4 ng/mL of 3β,5β-THP 
were used. 0.5 ng/mL and 0.2 ng/mL of every steroid was used for the 
middle and high QC, respectively. Each QC sample was analyzed in 
duplicate accompanied by a set of calibration samples. The determina-
tion of the intra-assay precision was performed in single runs, while 
inter-assay precision was derived from four independent measurements 
held on four different days. Both values were stated as relative standard 
deviations (RSD, %) and are a measure for repeatability and reproduc-
ibility. Accuracy, on the other hand, was calculated as a median relative 
error. Accuracy and precision were satisfactory when they were in the 
range of ±20% for the low QC and ±15% for the middle and high levels. 
2.6.5. Recovery and matrix effect 
Recovery and matrix effect in plasma were evaluated at three 
different concentrations for each analyte: 0.4 ng/mL (low), 6 ng/mL 
(middle) and 18 ng/mL (high) and by performing measurements in 
triplicate in two runs (n = 6). In total, three sample series had to be 
conducted: standards spiked into pure solvent, pre-extracted spiked 
samples and post-extracted spiked samples. In a first step, the recovery 
of extraction (RE) of each analyte had to be determined using equation 




× 100 (1) 
Thereby C corresponds to the peak area of the analyte recorded that 
was spiked into a blank plasma sample before the extraction, whereas B 
is considered to be the peak area at a recovery of 100% by spiking blank 
plasma after its extraction. 
Matrix effects (ME), on the other hand, are caused by various com-
pounds inside the plasma extract that have an impact on the quality of 




× 100 (2)  
with A being the peak area of the standard analyte dissolved in mere 
reconstitution solution (50% acetonitrile + 0.1% formic acid). Thus, 
possible values bear the following meaning: <100% ≙ ion suppression, 
100% ≙ no matrix effect and >100% ≙ ion enhancement. 
3. Results and discussion 
3.1. Method optimization 
3.1.1. Development of a purification protocol 
SPE was chosen as the purification technique in order to obtain 
interferent-free samples suitable for injection. Various types of car-
tridges were evaluated for the treatment of bovine plasma of a six-month 
pregnant cow. Among them were the Strata-X (30 mg, 1 mL and 60 mg, 
3 mL) and the Strata-X-A (30 mg, 1 mL) from Phenomenex (Torrance, 
CA, USA) as well as the Oasis PRiME HLB (30 mg, 1 mL) from Waters. 
Different solvent mixtures based on H2O, MeOH, MeCN, ethyl acetate 
and hexane were tested for optimization of the extraction conditions. 
The optimal procedure was to first dilute the plasma samples with 4% 
aqueous H3PO4 and, after loading and washing the SPE cardridges, elute 
the analytes with a mixture of H2O/MeCN/MeOH. The lowest efficiency 
was obtained with the Strata-X-A, while the Strata-X and Oasis PRiME 
HLB had similarly high extraction efficiencies. However, the solubility 
of the Oasis PRiME HLB residue in MeCN/H2O 1:1 was inferior to the 
Strata-X so that the Strata-X cartridge (60 mg, 3 mL) was finally chosen. 
The choice of reconstitution solvent was adjusted to the starting con-
ditions of the chromatographic gradient. 
3.1.2. Optimization of UHPLC-MS conditions 
Working with heated (+)-ESI settings was of advantage as steroids 
were readily ionized to give adduct ions such as [M+H]+ and [M-H2O +
H]+, which led to high sensitivity. The parameters responsible for the 
sensitivity of the MS, such as gas flow, ion source temperature and 
voltage, were optimized using a steroid standard mixture (1 μg/mL) 
injected at a flow rate of 10 μL/min. Using a targeted single ion 
Table 1 
Chemical formula and monoisotopic masses of all targeted analytes as well as corresponding retention times, monitored ions and multiplexing count. (*coeluting 
compounds).  
Compound Formula Neutral monoisotopic mass (u) Monitored single ions (m/z) Adduct RT min MSX count ISTD 
20α-DHP C21H32O2 316.2402 317.2475 [M+H]+ 2.61 1 P4-d9 
20β-DHP C21H32O2 316.2402 317.2475 [M+H]+ 3.76 1 P4-d9 
3α-DHP C21H32O2 316.2402 299.2369 [M-H2O + H]+ 4.21 1 P5-d4 
3β-DHP* C21H32O2 316.2402 299.2369 [M-H2O + H]+ 3.52 1 P5-d4 
5α-DHP C21H32O2 316.2402 317.2475 [M+H]+ 5.94 1 P5-d4 
5β-DHP C21H32O2 316.2402 299.2369 [M-H2O + H]+ 5.81 1 P5-d4 
3α,5α-THP C21H34O2 318.2559 301.2526 [M-H2O + H]+ 5.33 2 P5-d4 
3α,5β-THP C21H34O2 318.2559 301.2526 [M-H2O + H]+ 4.72 2 P5-d4 
3β,5α-THP C21H34O2 318.2559 301.2526 [M-H2O + H]+ 4.18 2 P5-d4 
3β,5β-THP C21H34O2 318.2559 301.2526 [M-H2O + H]+ 4.44 2 P5-d4 
P4 C21H30O2 314.2246 315.2319 [M+H]+ 3.92 3 P4-d9 
P5* C21H32O2 316.2402 299.2369 [M-H2O + H]+ 3.52 1 P5-d4 
P5-d4 C21H28D4O2 320.2653 303.2478 [M-H2O + H]+ 3.47 3 – 
P4-d9 C21H21D9O2 323.2810 324.2883 [M +H]+ 3.85 4 –  
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monitoring (t-SIM) approach gave us the most sensitive detection mode 
for the steroids after also testing the options of PRM (parallel reaction 
monitoring) and full scan acquisition. The targeted ions were selected 
based on the most intense signal of each compound in the full scan 
mode. 
Several UHPLC columns were evaluated to obtain the best chro-
matographic separation. Thereby, the Waters ACQUITY UPLC HSS T3 
column (2.1 × 100 mm, 1.8 μm particle size) yielded the best peak 
shapes, the highest signal response as well as the greatest steroid sepa-
ration power in the shortest time in comparison to Waters ACQUITY 
UPLC BEH C18 (2.1 × 100 mm, 1.8 μm particle size) and ACQUITY 
UPLC CSH C18 (2.1 × 100 mm, 1.8 μm particle size) columns. MeCN and 
H2O as eluents provided low backpressure throughout all measure-
ments, and 0.1% formic acid was chosen as additive due to its superior 
ionization efficiency of progestagens compared to ammonium formate 
and ammonium fluoride. A column temperature of 25 ◦C gave the best 
chromatographic separation, while higher temperatures promoted co- 
elution. The flow rate was optimized to give the best resolution at the 
highest possible flow rate of 0.45 mL/min. Finally, the elution gradient 
was adjusted to obtain the optimal separation of the analytes. 
3.2. Method validation 
3.2.1. Selectivity 
The criteria for selectivity were chromatographic retention times, 
high-resolution separation as well as accurate masse detection of the 
selected ions. The retention time of all analytes ranged from 2.61 to 5.94 
min as presented in Table 1 and remained stable throughout measure-
ments. An overview of the chromatographic separation is presented in 
Fig. 2 where EICs of the five targeted ions corresponding to the analytes 
measured as standard solutions are collected. In Fig. 3, EICs of the 
analytes are represented in completely blank matrix (A), in blank matrix 
spiked with ISTDs (B), a typical QC sample at the 0.5 ng/mL concen-
tration as well as inside three authentic samples (D-F). Even at low 
concentrations, well-defined peaks were found with the exception of the 
two 5-DHP isomers, which partially co-eluted at 5.81 and 5.94 min, and 
P5 and 3β-DHP, which overlapped at 3.52 min. These two pairs of 
isobaric steroids vary only in the position of a double bond and are 
therefore structurally greatly similar. All other analytes were success-
fully separated by means of chromatography or their ions had different 
masses. No serious interferences were found in the blank plasma at the 
retention time of all analytes and the ISTDs. A high resolution of 35,000 
was chosen in order to observe an appropriate baseline level in the 
chromatograms. 
3.2.2. Carry-over 
Peak areas of pure MeOH and blank plasma samples were investi-
gated after a previous injection of a 1 μg/mL standard solution, a con-
centration that is at least 100 times higher than to be expected in an 
authentic sample. Small peaks were found in the blank solvent for the 
compounds 20α-DHP, 20β-DHP and P4 as they are readily ionizable. 
However, their area fulfilled the criteria to be below 20% of the peak 
area of the LOQ sample. Concerning the plasma blank, no carry-over was 
determined. The minimal carry-over observed in the blank solvent most 
likely vanished in the higher background noise. 
3.2.3. Limit of detection, limit of quantification and standard calibration 
curves 
The limit of detection ranged from 0.005 to 0.1 ng/mL, whereas the 
limit of quantification was determined as 0.02–0.3 ng/mL (Table 2). 
Thereby, same values were obtained for diastereoisomers due to their 
similar ionizability with the exception of the 3-DHP compounds as well 
as 3β,5β-THP. Concerning the 3-DHP derivatives, 3β-DHP was coeluting 
with P5 and its detection limit is hence overestimated (0.02 ng/mL) and 
lower than of 3α-DHP (0.05 ng/mL). In contrast to this, the limit of 
quantification was three times higher for 3β,5β-THP (0.3 ng/mL) 
compared with the remaining tetrahydroprogestagens (0.1 ng/mL). This 
higher limit of quantification had to be set after the measurement of the 
compound in authentic plasma samples. Compared to charcoal stripped 
plasma, authentic samples own a more complex matrix and thus, ion 
suppression was sometimes an issue for the 3β,5β-THP steroid at lower 
concentrations. To ensure reliable values even for authentic samples, the 
LOQ of 3β,5β-THP was increased. The lowest LOD and LOQ could be 
attributed to the steroids P4, 20α- and 20β-DHP that all are character-
ized by a conjugated ketone. Because of these different sensitivities, 2 
ISTD were taken. P4-d9 was chosen for the compounds with lowest LOD, 
whereas P5-d4 was suitable for the less ionizable compounds (3α,5α- 
THP, 3α,5β-THP, 3β,5α-THP, 3β,5β-THP, 3α-DHP, 3β-DHP, 5α-DHP, 5β- 
DHP and P5). Nevertheless, the overall sensitivity was adequate to 
investigate biological systems where steroid hormones are often pro-
duced at only low quantities in the range of ng/mL or even pg/mL. The 
correlation coefficients for the regression equations were generated for 
each measurement sequence (n = 4) and were always higher than 0.99 
indicating a very good, reproducible fit. 
Fig. 2. Overlaid extracted ion chromatograms (±5 ppm) of quantifying ions (see Table 1) measured from standard solutions of equal concentration.  
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Least squares regression analysis yielded the result of a quadratic 
fitting model with an equal weighting for the ratio of the peak area of the 
analyte and its ISTD against the nominal concentration. The curve was 
forced through the origin to obtain more accurate values at low con-
centrations. Illustrated in Fig. 4, a large dynamic range can be observed 
for all analytes up to 240 ng/mL from which point on the curve begins to 
flatten. This non-linearity at high concentrations is common for ESI 
measurements and can be explained by ionization and/or detector 
saturation as well as the formation of dimer/cluster ions [23]. 
3.2.4. Accuracy and precision 
Accuracy and precision of the method were evaluated at three 
different concentration levels of QC samples in duplicate on four 
different days. The QC levels (between 0.06 and 2 ng/mL) were chosen 
to cover the most relevant biological range expected in authentic sam-
ples to ensure high data quality. The accuracy is given as a relative error 
(RE, %), whereas intra- and inter-day precision were calculated as a 
relative standard deviation (RSD, %). The results are summarized in 
Table 3. The relative error of the accuracy ranged from −12.3% to 
10.4% for all compounds. The precision was very good for most pro-
gestagens with RSD values between 1.1% and 15.7%. Only 3α-DHP 
shows a higher precision deviation up to 17.4% and is thus slightly 
above our criteria to have a precision below 15% at all concentrations. 
Fig. 3. Overlaid extracted ion chromatograms (±5 
ppm) of quantifying ions (see Table 1) of authentic 
samples measured by UHPLC-MS using msx t-SIM 
(multiplexed targeted single ion monitoring) in the 
relevant time range between 2.5 and 6.5 min. (A) 
Charcoal treated plasma sample; (B) blank plasma 
sample spiked with both ISTDs; (C) representative 
0.5 ng/mL QC sample; (D) authentic plasma sample 
of a roe deer (Capreolus capreolus); (E) authentic 
plasma sample of a cow (Bos taurus); (F) authentic 
serum sample of an Asian elephant (Elephas maximus).   
Table 2 
Limits of detection and quantifications for all steroid hormones together with the 
smallest value obtained for the correlation coefficient comparing all calibration 
curves (n = 4).  
Analyte LOD (ng/mL) LOQ (ng/mL) R2 (a.u.) 
20α-DHP 0.005 0.02 ≥0.9998 
20β-DHP 0.005 0.02 ≥0.9998 
3α-DHP 0.05 0.1 ≥0.9933 
3β-DHP 0.02 0.05 ≥0.9988 
5α-DHP 0.1 0.2 ≥0.9962 
5β-DHP 0.1 0.2 ≥0.9969 
3α,5α-THP 0.05 0.1 ≥0.9982 
3α,5β-THP 0.05 0.1 ≥0.9996 
3β,5α-THP 0.05 0.1 ≥0.9987 
3β,5β-THP 0.05 0.3 ≥0.9996 
P4 0.005 0.05 ≥0.9989 
P5 0.02 0.05 ≥0.9988  
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3.2.5. Recovery and matrix effect 
In order to investigate the extraction efficiency of the SPE procedure 
over a broad range, recovery and matrix effects were investigated using 
three-levelled steroid concentrations as listed in Table 4. Relative stan-
dard deviations were calculated from the mean of six measurements for 
each sample. In plasma samples, the recovery at the low concentration of 
0.4 ng/mL was above 50% in all cases. For the middle and high con-
centration levels, the recovery lied between 62.8% and 109.6%. Matrix 
effects beneath 100% indicate ion suppression, whereas values above 
100% refer to ion enhancement. For 20β-DHP, the most ion suppression 
was observed at the low concentration (0.4 ng/mL) with 44.3%. 
However, little matrix effects were overall noted. For example, at high 
concentrations, the matrix effect was between 63.4% and 105.1%. Thus, 
only little amounts are lost during the SPE purification and most of the 
possible interferents were removed efficiently. 
3.3. Applicability 
3.3.1. Progestogen profiling in plasma of cyclic cattle (Bos taurus) 
Progestogens in 145 plasma samples of five different cows were 
successfully quantified by our established method. Due to the method’s 
high sensitivity, several progestogens were detected and monitored in a 
Fig. 4. Exemplary calibration curves of all analytes based on a quadratic fit and forced through the origin.  
Table 3 
Calculated validation results including accuracy (bias), intra- (RSDR) and inter- (RSDT) day precision (n = 8).  
Analyte QC level Concentration (ng/mL) Mean calculated concentration (ng/mL) Bias (%) RSDR (%) RSDT (%) 
20α-DHP low 0.06 0.058 −2.7 6.8 5.5 
middle 0.5 0.524 4.8 4.0 5.1 
high 2.0 1.943 −2.9 5.1 6.7 
20β-DHP low 0.06 0.061 0.8 3.0 3.5 
middle 0.5 0.506 1.1 2.9 3.7 
high 2.0 1.910 −4.5 5.2 8.5 
3α-DHP low 0.2 0.175 −12.3 17.3 14.9 
middle 0.5 0.505 1.0 13.0 10.7 
high 2.0 1.872 −6.4 13.0 17.4 
3β-DHP low 0.06 0.066 10.4 6.9 8.2 
middle 0.5 0.518 3.6 3.1 3.7 
high 2.0 1.890 −5.5 5.0 5.2 
5α-DHP low 0.2 0.222 11.1 8.9 9.3 
middle 0.5 0.510 2.0 4.0 4.1 
high 2.0 1.915 −4.2 5.0 7.1 
5β-DHP low 0.2 0.204 1.9 8.0 6.3 
middle 0.5 0.510 1.9 1.4 2.2 
high 2.0 2.011 0.6 6.7 6.3 
3α,5α-THP low 0.2 0.198 −1.1 5.2 7.1 
middle 0.5 0.497 −0.5 1.5 4.0 
high 2.0 1.955 −2.3 4.4 5.2 
3α,5β-THP low 0.2 0.185 −7.3 3.7 15.7 
middle 0.5 0.518 3.7 1.1 2.9 
high 2.0 1.984 −0.8 3.2 7.7 
3β,5α-THP low 0.2 0.198 −2.6 4.5 11.3 
middle 0.5 0.510 2.0 3.1 3.4 
high 2.0 1.894 −5.3 5.2 7.1 
3β,5β-THP low 0.4 0.400 −0.1 4.5 4.9 
middle 0.5 0.515 3.0 4.9 4.1 
high 2.0 1.939 −3.1 1.5 4.0 
P4 low 0.06 0.063 5.2 4.0 5.7 
middle 0.5 0.505 1.0 4.0 3.0 
high 2.0 1.876 −6.2 5.7 7.2 
P5 low 0.06 0.066 10.4 6.9 8.2 
middle 0.5 0,519 3.6 3.1 3.7 
high 2.0 1.890 −5.5 5.0 5.2  
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time-resolved fashion over the course of multiple weeks giving valuable 
insight in the reproductive biology in cattle. The corresponding data and 
their interpretation have been published by Hankele et al. [24]. 
3.3.2. Progestogen profiling in plasma of female roe deer (Capreolus 
capreolus) 
Over 100 plasma samples of individual roe deer have also been 
analyzed with this method with a focus on the course of embryonic 
diapause in the European roe deer. Again, several progestagens were 
detected and quantified. The data are described in more detail in the 
publication of van der Weijden et al. [25]. 
3.3.3. Progestogen profiling in serum of pregnant Asian elephants (Elephas 
maximus) 
The applicability of our novel method was further proven by the 
measurement of progestogens in 130 serum samples of pregnant Asian 
elephants. Contrary to most mammals, the most abundant circulating 
progestogen in elephants is not P4 but its 5α reduced form [26]. Since 
our method allows the detection and quantification of both, P4 and its 
reduced metabolites, it is highly suitable for studying gestagens in fe-
male elephants. We were able to successfully quantify several proges-
tagens as well as the low amounts of progesterone in the serum of 
pregnant elephants over the course of pregnancy until parturition (data 
not shown). 
4. Conclusion 
A functional and high-throughput UHPLC-HRMS protocol based on a 
Q Exactive mass spectrometer was established and validated for the 
simultaneous quantification of twelve progestogens (20α-DHP, 20β- 
DHP, 3α,5α-THP, 3α,5β-THP, 3β,5α-THP, 3β,5β-THP, 3α-DHP, 3β-DHP, 
5α-DHP, 5β-DHP, P5, P4) in plasma and serum with a run time of only 
14 min per sample. A purification process was developed by an opti-
mized SPE method without the need for a labor-intensive derivatization 
step. The instrumental method was based on UHPLC-HR-MS employing 
ESI ionization and multiplexed t-SIM that achieved a high sensitivity in 
the range of pg/mL as well as a good selectivity sufficient for biological 
systems. All validation tests were successfully conducted and showed 
that charcoal stripped bovine plasma is a first-rate choice as a surrogate 
matrix. Accuracy tests resulted in adequate values within ±13%. The 
intra- and interday precision were determined as being under 17.4%. 
The applicability was proven by the quantification of progestogens in 
cattle and roe deer plasma as well as elephant serum samples. Thus, this 
quantification method can be easily applied for routine analyses in 
various species including humans. 
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